Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;30(4):423-433.
doi: 10.1007/s13365-024-01217-8. Epub 2024 Jun 10.

CD4 nadir and neurocognitive trajectories in people living with HIV

Affiliations

CD4 nadir and neurocognitive trajectories in people living with HIV

Razmig Garabet et al. J Neurovirol. 2024 Aug.

Abstract

Human immunodeficiency virus-associated neurocognitive disorders persist in the combination antiretroviral therapy era. CD4 nadir is a well-established predictor of cognition cross-sectionally, but its impact on longitudinal neurocognitive (NC) trajectories is unclear. The few studies on this topic examined trajectories of global cognition, rather than specific NC domains. The current study examined CD4 nadir in relation to domain-specific NC decline. 132 HIV + adults from the Temple/Drexel Comprehensive NeuroHIV Center, Clinical and Translational Research Support Core Cohort were administered comprehensive NC assessments longitudinally, with last visit occurring an average of 12 years after CD4 nadir. Linear mixed models were used to examine CD4 nadir in relation to longitudinal NC trajectories in three empirically identified NC domains: speed/executive function (S/EF), visuospatial memory (VM), and verbal fluency (VF). CD4 nadir was associated with change in VF (p = 0.020), but not with S/EF or VM. Specifically, those with CD4 nadir < 200 demonstrated increasing VF over time (p = .002), whereas those with CD4 nadir > 200 demonstrated stable VF (p = .568), though these differing trajectories may partly reflect regression to the mean or differential practice effect. CD4 dynamics over time were analyzed as potential mechanisms for the identified associations, with mixed findings. While low CD4 nadir has been associated with weaker neurocognition among people living with HIV, the results of this study suggest that low CD4 nadir is not associated with ongoing decline a decade later. Nadir-related deficits in VF may be stable or even improve over time, possibly reflecting the beneficial cognitive effects of long-term treatment and immune reconstitution.

Keywords: CD4 nadir; HAND; HIV; Longitudinal; Neurocognition.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
CD4 nadir was associated with the trajectory of VF, but not S/EF or VM. Baseline global cognitive status was associated with the trajectory of S/EF and VM, but not of VF. Graphs depict domain-specific cognitive trajectories by CD4 nadir (left) and baseline global cognitive status (right). P values represent the effect of CD4 nadir * time since nadir (left) or the effect of baseline global cognitive status * time since nadir (right). CD4n = CD4 nadir

Similar articles

Cited by

References

    1. Aung HL, Siefried KJ, Gates TM et al (2023) Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not. EClinicalMedicine 56. 10.1016/j.eclinm.2022.101792 - PMC - PubMed
    1. Bernal B, Ardila A, Rosselli M (2015) Broca’s area network in language function: a pooling-data connectivity study. Front Psychol 6. 10.3389/FPSYG.2015.00687 - PMC - PubMed
    1. Benedict RHB (1997) Brief Visuospatial Memory Test – Revised. Psychological Assessment Resources, Odessa, FL
    1. Benton AL, Hamsher K, Sivan AB (1994) Multilingual Aphasia Examination. AJA Associates, Iowa City
    1. Chiang MC, Dutton RA, Hayashi KM et al (2007) 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage 34:44–60. 10.1016/J.NEUROIMAGE.2006.08.030 - PMC - PubMed

Publication types

MeSH terms

Substances